Myriad Genetics to Release Fourth-Quarter Financial Results
SALT LAKE CITY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing
Globe Newswire22-02-2023, 19:06
WHR Global Releases “Ask the Expert” 2023 Destination Services Benchmark Report 25-04-2023, 17:39